Anzeige
❌
Mehr »
Samstag, 21.11.2026 - Börsentäglich über 12.000 News
Zufall oder Strategie? Copper One zündet die nächste Stufe seiner Kupfer-Offensive!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
MP

WKN: A3EQWL | ISIN: US60458C1045 | Ticker: K6S
Tradegate
20.11.26 | 15:39
0,348 Euro
+28,22 % +0,077
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
MIRA PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
MIRA PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,2680,27213:04
0,2660,29120.11.

Aktuelle News zur MIRA PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiMIRA Pharmaceuticals reports preclinical data for MIRA-55 pain drug1
29.10.MIRA Pharmaceuticals reports weight loss data for SKNY-1 drug2
29.10.Mira Pharmaceuticals, Inc.: MIRA Pharmaceuticals Reports Significant Weight and Fat Reduction With Oral SKNY-1 in Obese Mice, Showing Favorable Lean-Mass and Weight-Regain Outcomes Compared With Semaglutide1
MIRA PHARMACEUTICALS Aktie jetzt für 0€ handeln
22.10.Mira Pharmaceuticals, Inc.: MIRA Pharmaceuticals Reports MIRA-55 Demonstrated Significant Pain Relief Comparable to Celebrex in Chronic Inflammatory Pain Study1
22.10.MIRA PHARMACEUTICALS, INC. - 8-K, Current Report1
17.09.Mira Pharmaceuticals, Inc.: MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review339MIAMI, Sept. 17, 2026 (GLOBE NEWSWIRE) -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel oral small-molecule therapeutics...
► Artikel lesen
16.09.MIRA PHARMACEUTICALS, INC. - 8-K, Current Report1
01.09.Why Is MIRA Pharmaceuticals Stock Gaining Tuesday?2
01.09.MIRA PHARMACEUTICALS, INC. - 8-K, Current Report2
12.08.MIRA PHARMACEUTICALS, INC. - 10-Q, Quarterly Report2
31.07.MIRA PHARMACEUTICALS, INC. - 8-K, Current Report5
30.07.MIRA Pharmaceuticals completes toxicology studies for two candidates2
30.07.MIRA Pharmaceuticals: Toxikologische Studien für zwei Wirkstoffkandidaten abgeschlossen5
10.07.MIRA Pharmaceuticals reports oral formulation progress for MIRA-551
10.07.MIRA Pharmaceuticals Reports Successful Formulation Results Supporting Development of MIRA-55 as a Non-Opioid Oral Therapy for Chronic Inflammatory Pain504Optimized Oral Formulation Demonstrates Favorable Oral Bioavailability Together with Robust Brain and Liver Distribution Following Oral Administration MIAMI, FL / ACCESS Newswire / July 10, 2026 / MIRA...
► Artikel lesen
06.07.MIRA Pharmaceuticals Reports Successful Formulation Results for SKNY-1, Its Oral Drug Candidate for Obesity and Addiction357New Preclinical Data Demonstrate Favorable Oral Bioavailability, Robust Brain Penetration and Liver Exposure with Once-Daily Dosing Potential MIAMI, FL / ACCESS Newswire / July 6, 2026 / MIRA Pharmaceuticals...
► Artikel lesen
06.07.MIRA PHARMACEUTICALS, INC. - 8-K, Current Report4
25.06.Mira Pharmaceuticals reports preclinical data on pain drug candidate3
25.06.MIRA Pharmaceuticals Reports New Preclinical Data Demonstrating Mira-55's Differentiated Mechanism of Action and Anxiolytic Activity Relative to THC398Data show Mira-55 does not produce the central nervous system effects associated with THC and acts through a distinct pharmacological mechanism, while demonstrating anxiolytic activity, which THC does...
► Artikel lesen
25.06.MIRA PHARMACEUTICALS, INC. - 8-K, Current Report2
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1